Northwest Biotherapeutics Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Northwest Biotherapeutics Inc.

NWBO 0.232

-8.3%

Oct 29 3:58 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who wrote (743)	1/18/2019 2:40:50 PM
From: Gary Mohilner	of 759

I've been an investor for just a few months at the advice of a knowledgeable friend. I hadn't looked at this site till today, and wished to learn other investors thoughts here. Is anyone thinking the annual meeting will bring greater recognition of what can be expected in the near future. From what I've seen to date, I cannot help by believe that the FDA will be impressed with the data from the trial once it's revealed as long as the numbers who're still alive for well over 3 years pointed out in Dr. Liau's presentation remain the case. I think it's clear this greatly exceeds what is occurring with SOC treatment and even if initial trial goals aren't met, longevity will be the key to approval. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next